v3.25.4
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2025
Stockholders’ Equity [Abstract]  
Schedule of Stock Option Activity

The following table provides the stock option activity for the years ended December, 2025 and 2024:

 

   Total Options Outstanding   Weighted Average Remaining Term (Years)   Weighted Average Exercise Price   Weighted Average Fair Value at Issue 
Outstanding January 1, 2024  6,068   7.02  $1,200.00  $918 
Issued  23,800      30.32   25.91 
Cancelled  (526)     1,646.90    
Outstanding December 31, 2024  29,342   9.01  $244.00  $ 
Issued  19,120      17.30   16.70 
Cancelled  (1,242)     257.10    
Outstanding December 31, 2025  47,220   8.58  $151.15  $ 
Outstanding December 31, 2025, vested and exercisable  19,661   7.85  $330.77  $ 
Schedule of Black Scholes Valuation Model to Determine the Fair Value of the Options Issued

The Company used the Black Scholes valuation model to determine the fair value of the options issued, using the following key assumptions for the years ended December 31, 2025 and 2024:

 

   December 31,
2025
   December 31,
2024
 
Fair Value per Share $17.25  $33.75-26.5 
Expected Term  5.75 years   5.75 years 
Expected Dividend $  $ 
Expected Volatility  114.2%  111.89-118.39%
Risk free rate  4.05%  4.09-4.29%
Schedule of Stock-Based Compensation Expense

The components of stock-based compensation expense included in the Company’s Statements of Operations for the years ended December 31, 2025 and 2024 are as follows:

 

   Year ended December 31, 
   2025   2024 
Research and development options expense $14,200   54,303 
Total research and development expenses  14,200   54,303 
General and administrative options expense  330,300   543,150 
Stock issued to vendors and employee  331,700   199,378 
Total general and administrative expenses  662,000   742,528 
Total stock-based compensation expense $676,200  $796,831 
Schedule of Activity in Warrants

The following table provides the activity in warrants for the respective periods.

 

   Total Warrants   Weighted
Average
Remaining
Term
(Years)
   Weighted Average Exercise Price   Average
Intrinsic
Value
 
Outstanding January 1, 2024  168,929   3.31  $194.16  $0.43 
Issued  94,760       71.01     
Exercised  (95,657)      41.83     
Outstanding December 31, 2024  168,032   2.07  $211.25  $0.01 
Issued  1,833,745       7.17     
Exercised  (753,092)      7.52     
Expired  (8,205)      1,389.35     
Outstanding December 31, 2025  1,240,480   3.1  $19.25  $0.00